ClinicalTrials.gov
public full text
Public Domain
CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
This is a prospective study using customized adherence enhancement (CAE) and long-acting injectable (LAI) antipsychotic in 30 individuals with bipolar disorder (BD) at risk for treatment non-adherence. The CAE approach is expected to improve treatment adherence, as well as improve BD symptoms, functioning and treatment attitudes among subjects with bipolar disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Role of Lifestyle on Adherence to Treatment in a Sample of Patients with Unipolar and Bipolar Depression#644197
- Antidepressant Adherence for Depressed Adults in Primary Care#994079
- Raw data from the large-scale validation study of the Barriers to Medication Adherence Questionnaire (CBAM) in adult polymedicated patients in Santa Fe, Argentina#654241
- Therapeutic Adherence Promotion Program for Severe Mental Illness: The ADHERA Study Protocol.#849
- Study to Promote Innovation in Rural Integrated Telepsychiatry#1164019
Record · ID 1150415
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive